Exact Sciences Corporation
EXAS
$45.66
-$1.81-3.81%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 2.94B | 2.83B | 2.76B | 2.69B | 2.61B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.94B | 2.83B | 2.76B | 2.69B | 2.61B |
| Cost of Revenue | 935.07M | 897.39M | 882.35M | 853.40M | 825.86M |
| Gross Profit | 2.00B | 1.93B | 1.88B | 1.84B | 1.79B |
| SG&A Expenses | 1.78B | 1.73B | 1.68B | 1.66B | 1.66B |
| Depreciation & Amortization | -46.62M | -46.62M | -46.62M | -44.41M | -45.86M |
| Other Operating Expenses | -- | -- | -- | -2.03M | -2.03M |
| Total Operating Expenses | 3.08B | 3.01B | 2.95B | 2.92B | 2.89B |
| Operating Income | -138.98M | -176.89M | -191.79M | -227.22M | -282.27M |
| Income Before Tax | -1.01B | -1.03B | -1.04B | -210.57M | -172.10M |
| Income Tax Expenses | -9.22M | -8.89M | -7.30M | 3.47M | 2.91M |
| Earnings from Continuing Operations | -1.01K | -1.02K | -1.03K | -214.04 | -175.01 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.01B | -1.02B | -1.03B | -214.04M | -175.01M |
| EBIT | -138.98M | -176.89M | -191.79M | -227.22M | -282.27M |
| EBITDA | 78.28M | 38.09M | 23.07M | -11.34M | -68.90M |
| EPS Basic | -5.42 | -5.50 | -5.56 | -1.17 | -0.96 |
| Normalized Basic EPS | -0.47 | -0.60 | -0.65 | -0.71 | -0.93 |
| EPS Diluted | -5.43 | -5.51 | -5.57 | -1.18 | -0.96 |
| Normalized Diluted EPS | -0.47 | -0.60 | -0.65 | -0.71 | -0.93 |
| Average Basic Shares Outstanding | 745.82M | 741.23M | 736.77M | 732.57M | 728.43M |
| Average Diluted Shares Outstanding | 745.82M | 741.23M | 736.77M | 732.57M | 731.85M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |